Wilson’s disease: A case report with review of literature by Narra, Ramakrishna et al.
Vol 4 | Issue 6 | Nov - Dec 2018 Indian J Case Reports 431
Case Report
Wilson’s disease: A case report with review of literature
Ramakrishna Narra1, Bhimeswara Rao2, Anusha Putcha3
From 1Additional Professor, 2Professor, 3Junior Resident, Department of Radiodiagnosis, Katuri Medical College, Guntur, Andhra Pradesh, India
Correspondence to: Dr. Ramakrishna Narra, Flat no: 30, 5 Floor, Venkatesh Estate Apartment, ½ Chandramouli Nagar, 
Guntur – 522 006, Andhra Pradesh, India.E-mail: narra.ramki29@gmail.com
Received - 12 October 2018 Initial Review - 26 October 2018 Accepted - 03 November 2018
Wilson’s disease is an autosomal recessive inborn error of copper metabolism caused due to mutation of ATP7B gene located on the chromosomal region 
13q21, which codes for the synthesis of an ATP7B protein [1]. 
ATP7B protein resides in the hepatocytes and its function is 
to incorporate six copper molecules into apoceruloplasmin 
and thus form ceruloplasmin. Mutation in the ATP7B gene 
leads to defective ATP7B protein and consequent progressive 
accumulation of copper in hepatocytes [2]. In Wilson’s disease, 
serum ceruloplasmin level will be low and excessive copper 
is seen in plasma and urine, leading to deposition of copper in 
various tissues such as liver, brain, and eyes.
The age of presentation in Wilson’s disease is from early 
childhood to 50 years [3]. Wilson’s disease has a slight male 
predominance (52%) [4]. Hepatic manifestations such as 
chronic liver disease or hemolytic anemia are more common in 
young children, whereas neurological manifestations are more 
common in young adults. Bilateral symmetrical basal ganglia 
and brainstem abnormalities are the most common findings on 
magnetic resonance imaging (MRI) in Wilson’s disease, followed 
by cerebral atrophy and asymmetric central white matter 
abnormalities. We report a case of a young adult who presented 
with neurologic manifestations and diagnosed as Wilson’s disease 
with typical MRI findings.
CASE REPORT
A 27-year-old female patient presented to the department with 
a history of slurring of speech, postural instability for 1 month, 
and tremors of the right upper limb for 10 days. No history of 
similar complaints in the family members was found. On general 
examination, the patient had no pallor, icterus, clubbing/cyanosis, 
and lymphadenopathy. The patient had stable vitals with a 
blood pressure of 130/80 mmHg, pulse rate=74/min, respiratory 
rate=14/min, and temperature=98°F. Neurological examination 
showed dysarthria, ataxic gait, and tremors of the right upper 
limb. The ophthalmological examination revealed Kayser–
Fleischer rings in both eyes (Fig 1).
The laboratory investigations included 
hemoglobin=13.4 g/dl (normal=12–15 g/dl); white blood 
cells=5.8 × 103/mm3 (normal=4.0–10.9 × 103/mm3), red blood 
cells=4.14 × 106/mm3 (normal=4.0–5.4 × 106/mm3), platelet 
count=202 × 103/mm3 (normal=150–400 × 103/mm3), serum 
ceruloplasmin=3.27 mg/dl (normal=18–35 mg/dl), and 24 h urine 
copper=230 µg/day (normal=2–80 µg/day).
Based on the clinical examination and above-mentioned 
investigations, a provisional diagnosis of Wilson’s disease was 
considered. The ultrasound of the abdomen showed coarse 
echotexture of the liver (Fig 2). However, liver function 
tests including total bilirubin, alkaline phosphatase, serum 
glutamic-oxaloacetic transaminase, and serum glutamic pyruvic 
transaminase were normal.
MRI of the brain revealed bilateral symmetrical T2-weighted 
(T2W) and FLAIR hyperintensities involving caudate, putamen, 
thalami, midbrain, pons, cerebellar dentate nuclei, and inferior 
cerebellar peduncle (Fig 3) with hypointense red nuclei and 
substantia nigra forming “face of giant panda” sign (Fig 4). The 
atrophy of bilateral putamen was noted. Mild hyperintensity on 
diffusion-weighted imaging noted in midbrain with minimal 
reduction of apparent diffusion coefficient values (Fig 5), 
and T1-weighted (T1W) hyperintensity noted in bilateral 
basal ganglia and subthalamic nuclei suggestive of hepatic 
encephalopathy (Fig 6).
Hence, a final diagnosis of Wilson’s disease was made, 
and treatment with penicillamine 750 mg/day and zinc acetate 
150 mg/day along with clonazepam 0.5 mg/day was initiated. 
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On subsequent follow-up after 1 week, the patient showed 
symptomatic improvement. 
DISCUSSION
Wilson’s disease is a rare autosomal recessive disorder of copper 
metabolism. The deposition of copper occurs in various tissues, 
leading to toxicity. An estimated worldwide prevalence of Wilson’s 
disease is one case per 30,000 live births in most populations [5]. 
Coffey et al. conducted a genetic study of Wilson’s disease using 
molecular sequencing in the United Kingdom which suggested a 
higher prevalence of one case in 7021 [6].
The early manifestations of Wilson’s disease include yellowish 
discoloration of the skin and mucous membranes and abnormal liver 
function tests due to hepatic dysfunction. Hepatic presentations may 
vary from acute liver failure, autoimmune hepatitis, cirrhosis, and 
hepatocellular carcinoma [7,8]. After the liver disease, neurological 
manifestations such as the flexion-extension tremor of a wrist, 
grimacing, difficulty in writing, slurred speech, and drooling 
Figure 1: Kayser–Fleischer ring noted at the periphery of the cornea 
inferiorly
Figure 6: T2-weighted magnetic resonance image showing 
hyperintensity in basal ganglia (arrow)
Figure 2: Ultrasound image showing coarse echotexture of liver
Figure 5: (a) Diffusion-weighted imaging magnetic resonance image 
showing hyperintensity in midbrain (arrow) and (b) apparent 
diffusion coefficient (ADC) map showing hypointensity in 
midbrain (arrow) due to minimal reduction of ADC values
ba
Figure 4: (a) T2-weighted and (b) VenBOLD magnetic resonance 
images showing “face of giant panda” sign in midbrain (arrow)
ba
Figure 3: T2-weighted magnetic resonance image showing 
bilateral, symmetric hyperintensities (a) involving caudate, 
putamen (arrow), thalami with atrophy of bilateral putamen; 
(b) involving midbrain (arrow) and (c) pons (arrow)
cba
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occur. Late manifestations of Wilson’s disease include psychiatric 
manifestations ranging from depression to schizophrenia, Kayser–
Fleischer rings, renal tubular damage, and osteoporosis. Deposition 
of copper in Descemet’s membrane of cornea leads to the appearance 
of characteristic Kayser–Fleischer rings seen in Wilson’s disease. 
Renal manifestations may include aminoaciduria, glycosuria, 
phosphaturia, uricosuria, and renal tubular acidosis.
Neuroimaging findings in Wilson’s disease include bilateral 
symmetrical involvement of putamen, caudate nuclei, globus 
pallidi, ventrolateral thalami, midbrain, pons, cerebellum, and 
cortical and subcortical lesions (usually in the frontal lobe) 
may also occur. On computed tomography scan, gray matter 
abnormalities appear as hypodensities that do not enhance on 
contrast. On MRI, they appear hypointense on T1W images and 
hyperintense on T2W images [9].
Pathologically gliosis, edema, and variable necrosis with 
cavitation occur due to neurotoxicity of copper [10,11], and this 
accounts for the hyperintense signal on T2W images. The normal 
signal intensity of red nucleus and substantia nigra against the 
background of hyperintense signal in tegmentum gives rise to the 
characteristic “face of giant panda” sign [12]. The “face of the 
miniature panda” sign is seen in the pons, caused by hypointensity 
of central tegmental tracts in contrast to the hyperintensity of the 
aqueduct opening into the fourth ventricle. The “double panda” 
sign refers to a combination of the face of giant panda and face 
of miniature panda signs [13]. The asymmetric, confluent T2W 
hyperintensities may be seen in the cortical gray matter and 
subcortical white matter. In a study by Jha et al., an incidence 
of white matter lesions was reported to be 10% [14]. Cerebellar 
atrophy and cerebral atrophy with dilatation of frontal horns of 
lateral ventricles may be seen in Wilson’s disease.
On T1W MRI, high-signal intensity is seen in the globus 
pallidus, putamen, and mesencephalon in association with hepatic 
dysfunction due to copper toxicosis. On diffusion-weighted MR, 
recent lesions show a restricted diffusion which is likely due to 
cytotoxic edema [15]. Kishibayashi et al. studied diffusion-weighted 
MRI in four patients with Wilson’s disease and noted abnormally 
high-signal intensity in some areas of basal ganglia in each case [16].
On MR spectroscopy, there will be reduced N-acetyl aspartate/
creatinine ratio in the involved areas and increase in myoinositol/
creatinine ratio [17]. Differential diagnosis of Wilson’s disease 
includes Leigh’s disease and hypoxic-ischemic encephalopathy. 
However, characteristic biochemical and radiological findings 
can differentiate them. In some cases, liver biopsy for copper 
analysis may be essential for confirmation of Wilson’s disease. 
The treatment for Wilson’s disease includes penicillamine which 
chelates copper from the body and zinc acetate which prevents 
the absorption of dietary copper from the gut. Prognosis is good if 
the treatment is initiated early. In 6–12 months, liver function will 
return to normal if the treatment is initiated when there is only 
mild-to-moderate liver failure [18].
CONCLUSION
Early diagnosis of Wilson’s disease with clinical, biochemical, 
and characteristic radiological findings is very essential to 
initiate the treatment early and to halt the progression of the 
disease.
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